Human trials begin in fortnight, J&J works to ramp up production of affordable COVID vaccine: Top scientist

The US-based pharma giant, which has already advanced its schedule of starting human trials of its candidate vaccine to the second half of July from September, is working on the twin fronts of expanding existing manufacturing capacity and establishing new units, Chief Scientific Officer Paul Stoffels told PTI.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dIMVF1
via IFTTT